Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.73)
# 666
Out of 4,491 analysts
377
Total ratings
57.3%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | $1,979.50 | +27.10% | 2 | May 26, 2026 | |
| SWX: COPN Cosmo N.V. | Maintained: Buy | CHF 130.00 | $65.00 | +100.00% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 80.00 | $69.20 | +15.61% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Maintained: Buy | €5.00 | $6.46 | -22.60% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Maintained: Buy | €8.20 | $3.36 | +143.90% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | $6.38 | -29.47% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Maintained: Buy | CHF 66.00 → CHF 73.00 | $50.60 | +44.27% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €85.00 | $75.37 | +12.78% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Maintained: Buy | €33.00 | $18.52 | +78.19% | 51 | Apr 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 280.00 | $318.25 | -12.02% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 | $15.29 | +32.77% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €36.60 | $28.76 | +27.26% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.00 | $2.81 | +77.94% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.00 | $8.79 | +70.65% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €390.00 | $323.00 | +20.74% | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €0.80 → €0.64 | $0.0153 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $90 → $47 | $30.72 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.00 → €41.00 | $26.80 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $390 → $428 | $912.35 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €342.00 → €375.00 | $806.30 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.66 | n/a | 3 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | $54.30 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | $2.60 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | $2.28 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | $4.25 | n/a | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €0.60 → €0.40 | $0.455 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €2.70 | $0.3825 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $3.81 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | $122.10 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: $1,979.50
Upside: +27.10%
Cosmo N.V.
May 11, 2026
Maintained: Buy
Price Target: CHF 130.00
Current: $65.00
Upside: +100.00%
Sandoz Group AG
May 11, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: $69.20
Upside: +15.61%
Carvolix SA
May 4, 2026
Maintained: Buy
Price Target: €5.00
Current: $6.46
Upside: -22.60%
OSE Immunotherapeutics SA
Apr 30, 2026
Maintained: Buy
Price Target: €8.20
Current: $3.36
Upside: +143.90%
Idorsia Ltd
Apr 28, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: $6.38
Upside: -29.47%
BB Biotech AG
Apr 24, 2026
Maintained: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: $50.60
Upside: +44.27%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: €85.00
Current: $75.37
Upside: +12.78%
Formycon AG
Apr 22, 2026
Maintained: Buy
Price Target: €33.00
Current: $18.52
Upside: +78.19%
Novo Nordisk A/S
Apr 20, 2026
Maintained: Hold
Price Target: kr 280.00
Current: $318.25
Upside: -12.02%
Apr 1, 2026
Maintained: Buy
Price Target: €20.30
Current: $15.29
Upside: +32.77%
Mar 6, 2026
Maintained: Buy
Price Target: €36.60
Current: $28.76
Upside: +27.26%
Feb 25, 2026
Maintained: Buy
Price Target: €5.00
Current: $2.81
Upside: +77.94%
Sep 25, 2025
Maintained: Hold
Price Target: €15.00
Current: $8.79
Upside: +70.65%
Jul 17, 2025
Maintained: Hold
Price Target: €390.00
Current: $323.00
Upside: +20.74%
May 6, 2024
Maintained: Sell
Price Target: €0.80 → €0.64
Current: $0.0153
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $90 → $47
Current: $30.72
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: €79.00 → €41.00
Current: $26.80
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: $390 → $428
Current: $912.35
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: €342.00 → €375.00
Current: $806.30
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: $14
Current: $1.66
Upside: n/a
Nov 20, 2023
Maintained: Buy
Price Target: CHF 57.00
Current: $54.30
Upside: n/a
Sep 7, 2023
Maintained: Buy
Price Target: €16.00
Current: $2.60
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: $2.28
Upside: n/a
Jun 22, 2023
Maintained: Buy
Price Target: €17.00
Current: $4.25
Upside: n/a
May 3, 2023
Maintained: Buy
Price Target: €0.60 → €0.40
Current: $0.455
Upside: n/a
Apr 28, 2023
Maintained: Buy
Price Target: €2.70
Current: $0.3825
Upside: n/a
Dec 29, 2022
Maintained: Buy
Price Target: €12.00
Current: $3.81
Upside: n/a
Dec 21, 2022
Maintained: Buy
Price Target: €16.00
Current: $122.10
Upside: n/a